Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Sonoma Pharmaceuticals, Inc. (SNOA) had Receiveable Turnover of 5.16 for the most recently reported fiscal year, ending 2023-03-31.
| Income Statement Financials | |
$13.27M |
|
$-5.15M |
|
$8.79M |
|
$4.48M |
|
$17.84M |
|
$-4.57M |
|
$-0.61M |
|
$-5.18M |
|
$-5.18M |
|
$-5.15M |
|
$-5.15M |
|
$-5.15M |
|
$-5.15M |
|
$-4.57M |
|
$-4.45M |
|
3.39M |
|
3.39M |
|
$-1.52 |
|
$-1.52 |
|
| Balance Sheet Financials | |
$13.80M |
|
$0.49M |
|
$2.43M |
|
$16.23M |
|
$3.72M |
|
-- |
|
$4.54M |
|
$8.25M |
|
$7.98M |
|
$7.98M |
|
$7.98M |
|
4.93M |
|
| Cash Flow Statement Financials | |
$-6.15M |
|
$-0.26M |
|
$2.49M |
|
$7.40M |
|
$3.82M |
|
$-3.58M |
|
$0.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.71 |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
33.73% |
|
-34.43% |
|
-34.43% |
|
-33.49% |
|
-39.06% |
|
-38.81% |
|
$-6.42M |
|
-- |
|
-- |
|
-- |
|
0.82 |
|
3.08 |
|
|
Receiveable Turnover |
5.16 |
70.73 |
|
-64.57% |
|
-64.57% |
|
-31.74% |
|
-64.57% |
|
$1.62 |
|
$-1.89 |
|
$-1.81 |
|